Insmed Incorporated(INSM)
Biotechnology
Rare Disease / Orphan Drug
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-06-10 | Lewis William Chair and CEO | Sale | -6,515 | -2.45%258,917 | $94.03 | $612,605 | View SEC filing | |
| 2026-06-05 | Smith Michael Alexander Chief Legal Officer | Sale | -2,159 | -5.19%39,454 | $102.27 | $220,801 | View SEC filing | |
| 2026-06-05 | Flammer Martina M.D. Chief Medical Officer | Sale | -4,424 | -6.82%60,486 | $102.90 | $455,248 | View SEC filing | |
| 2026-06-05 | Adsett Roger Chief Operating Officer | Sale | -2,370 | -2.35%98,603 | $102.27 | $242,380 | View SEC filing | |
| 2026-06-05 | Bonstein Sara Chief Financial Officer | Sale | -2,404 | -3.36%69,082 | $102.27 | $245,857 | View SEC filing | |
| 2026-06-05 | Lewis William Chair and CEO | Sale | -7,605 | -2.79%265,432 | $102.27 | $777,763 | View SEC filing | |
| 2026-05-22 | Smith Michael Alexander Chief Legal Officer | Sale | -6,149 | -12.87%41,613 | $108.47 | $666,982 | View SEC filing | |
| 2026-05-20 | Lewis William Chair and CEO | Sale | -25,564 | -8.56%273,037 | $106.33 | $2,718,224 | View SEC filing | |
| 2026-05-13 | Flammer Martina M.D. Chief Medical Officer | Sale | -12,949 | -13.46%83,243 | $100.40 | $1,300,121 | View SEC filing | |
| 2026-05-06 | Lewis William Chair and CEO | Sale | -10,699 | -3.43%301,185 | $137.34 | $1,469,442 | View SEC filing | |
| 2026-04-17 | Lewis William Chair and CEO | Sale | -10,699 | -3.43%301,185 | $143.97 | $1,540,332 | View SEC filing | |
| 2026-04-08 | Lewis William Chair and CEO | Sale | -10,699 | -3.43%301,185 | $163.22 | $1,746,336 | View SEC filing | |
| 2026-04-03 | Adsett Roger Chief Operating Officer | Sale | -88,060 | -45.19%106,810 | $164.63 | $14,497,651 | View SEC filing | |
| 2026-03-31 | Smith Michael Alexander Chief Legal Officer | Sale | -19,638 | -27.46%51,871 | $150.98 | $2,964,945 | View SEC filing | |
| 2026-03-20 | Lewis William Chair and CEO | Sale | -10,699 | -3.43%301,185 | $143.52 | $1,535,542 | View SEC filing | |
| 2026-03-05 | Lewis William Chair and CEO | Sale | -10,699 | -3.43%301,185 | $146.03 | $1,562,328 | View SEC filing | |
| 2026-02-25 | Smith Michael Alexander Chief Legal Officer | Sale | -24,774 | -32.32%51,871 | $155.77 | $3,859,157 | View SEC filing | |
| 2026-02-23 | Lewis William Chair and CEO | Sale | -10,699 | -3.43%301,185 | $150.97 | $1,615,257 | View SEC filing | |
| 2026-02-11 | Lewis William Chair and CEO | Sale | -13,396 | -4.26%301,185 | $147.79 | $1,979,764 | View SEC filing | |
| 2026-02-06 | Flammer Martina M.D. Chief Medical Officer | Sale | -869 | -1.03%83,243 | $152.44 | $132,470 | View SEC filing | |
| 2026-02-04 | Smith Michael Alexander Chief Legal Officer | Sale | -640 | -1.12%56,397 | $156.27 | $100,013 | View SEC filing | |
| 2026-02-04 | Flammer Martina M.D. Chief Medical Officer | Sale | -8,777 | -9.45%84,112 | $154.70 | $1,357,796 | View SEC filing | |
| 2026-02-04 | Adsett Roger Chief Operating Officer | Sale | -791 | -0.74%106,810 | $156.17 | $123,530 | View SEC filing | |
| 2026-02-04 | Bonstein Sara Chief Financial Officer | Sale | -748 | -0.93%79,758 | $156.34 | $116,942 | View SEC filing | |
| 2026-02-04 | Lewis William Chair and CEO | Sale | -3,009 | -0.98%303,882 | $156.34 | $470,427 | View SEC filing |
1-25 of 305